This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, Y. Articles by Aldaz, C. M. Search for Related Content PubMed PubMed Citation Articles by Hu, Y. Articles by Aldaz, C. M.

From Mice to Humans

Identification of Commonly Deregulated Genes in Mammary Cancer via Comparative SAGE Studies

¹ Department of Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville; ² Baylor College of Medicine, Department of Molecular and Cellular Biology, Houston; ³ Rice University, Houston; and Departments of ⁴ Pathology and ⁵ Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Genetically engineered mouse mammary cancer models have been used over the years as systems to study human breast cancer. However, much controversy exists on the utility of such models as valid equivalents to the human cancer condition. To perform an interspecies gene expression comparative study in breast cancer we used a mouse model that most closely resembles human breast carcinogenesis. This system relies on the transplant of p53 null mouse mammary epithelial cells into the cleared mammary fat pads of syngeneic hosts. Serial analysis of gene expression (SAGE) was used to obtain gene expression profiles of normal and tumor samples from this mouse mammary cancer model (>300,000 mouse mammary-specific tags). The resulting mouse data were compared with 25 of our human breast cancer SAGE libraries (>2.5 million human breast-specific tags). We observed significant similarities in the deregulation of specific genes and gene families when comparing mouse with human breast cancer SAGE data. A total of 72 transcripts were identified as commonly deregulated in both species. We observed a systematic and significant down-regulation in all of the tumors from both species of various cytokines, including CXCL1 (GRO1), LIF, interleukin 6, and CCL2. All of the mouse and most human mammary tumors also displayed decreased expression of genes known to inhibit cell proliferation, including NFKBIA (IKB), GADD45B, and CDKN1A (p21); transcription-related genes such as CEBP, JUN, JUNB, and ELF1; and apoptosis-related transcripts such as IER3 and GADD34/PPP1R15A. Examples of overexpressed transcripts in tumors from both species include proliferation-related genes such as CCND1, CKS1B, and STMN1 (oncoprotein 18); and genes related to other functions such as SEPW1, SDFR1, DNCI2, and SP110. Importantly, abnormal expression of several of these genes has not been associated previously with breast cancer. The consistency of these observations was validated in independent mouse and human mammary cancer sets.

This is the first interspecies comparison of mammary cancer gene expression profiles. The comparative analysis of mouse and human SAGE mammary cancer data validates this p53 null mouse tumor model as a useful system closely resembling human breast cancer development and progression. More importantly, these studies are allowing us to identify relevant biomarkers of potential use in human studies while leading to a better understanding of specific mechanisms of human breast carcinogenesis.

This article has been cited by other articles:

				S. Lu, K. A. Becker, M. J. Hagen, H. Yan, A. L. Roberts, L. A. Mathews, S. S. Schneider, H. T. Siegelmann, K. J. MacBeth, S. M. Tirrell, et al. Transcriptional Responses to Estrogen and Progesterone in Mammary Gland Identify Networks Regulating p53 Activity Endocrinology, October 1, 2008; 149(10): 4809 - 4820. [Abstract] [Full Text] [PDF]

				T. Sasada, K. Azuma, T. Hirai, H. Hashida, M. Kanai, T. Yanagawa, and A. Takabayashi Prognostic Significance of the Immediate Early Response Gene X-1 (IEX-1) Expression in Pancreatic Cancer Ann. Surg. Oncol., February 1, 2008; 15(2): 609 - 617. [Abstract] [Full Text] [PDF]

				M. Wu, D. R. Soler, M. C. Abba, M. I. Nunez, R. Baer, C. Hatzis, A. Llombart-Cussac, A. Llombart-Bosch, and C. M. Aldaz CtIP Silencing as a Novel Mechanism of Tamoxifen Resistance in Breast Cancer Mol. Cancer Res., December 1, 2007; 5(12): 1285 - 1295. [Abstract] [Full Text] [PDF]

				M. C. Abba, H. Sun, K. A. Hawkins, J. A. Drake, Y. Hu, M. I. Nunez, S. Gaddis, T. Shi, S. Horvath, A. Sahin, et al. Breast Cancer Molecular Signatures as Determined by SAGE: Correlation with Lymph Node Status Mol. Cancer Res., September 1, 2007; 5(9): 881 - 890. [Abstract] [Full Text] [PDF]

				M. C. Abba, V. T. Fabris, Y. Hu, F. S. Kittrell, W.-W. Cai, L. A. Donehower, A. Sahin, D. Medina, and C. M. Aldaz Identification of Novel Amplification Gene Targets in Mouse and Human Breast Cancer at a Syntenic Cluster Mapping to Mouse ch8A1 and Human ch13q34 Cancer Res., May 1, 2007; 67(9): 4104 - 4112. [Abstract] [Full Text] [PDF]

				M. Singh and L. Johnson Using genetically engineered mouse models of cancer to aid drug development: an industry perspective. Clin. Cancer Res., September 15, 2006; 12(18): 5312 - 5328. [Abstract] [Full Text] [PDF]

				D. G. Peters, W. Ning, T. J. Chu, C. J. Li, and A. M. K. Choi Comparative SAGE analysis of the response to hypoxia in human pulmonary and aortic endothelial cells Physiol Genomics, September 14, 2006; 26(2): 99 - 108. [Abstract] [Full Text] [PDF]

				B. Dave, R. R. Eason, Y. Geng, Y. Su, T. M. Badger, and R. C. M. Simmen Tp53-Associated Growth Arrest and DNA Damage Repair Gene Expression Is Attenuated in Mammary Epithelial Cells of Rats Fed Whey Proteins J. Nutr., May 1, 2006; 136(5): 1156 - 1160. [Abstract] [Full Text] [PDF]

				M.-L. Kruse, A. Arlt, A. Sieke, F. Grohmann, M. Grossmann, J. Minkenberg, U. R. Folsch, and H. Schafer Immediate Early Gene X1 (IEX-1) Is Organized in Subnuclear Structures and Partially Co-localizes with Promyelocytic Leukemia Protein in HeLa Cells J. Biol. Chem., July 1, 2005; 280(26): 24849 - 24856. [Abstract] [Full Text] [PDF]

				V. M. Golubovskaya, R. Finch, and W. G. Cance Direct Interaction of the N-terminal Domain of Focal Adhesion Kinase with the N-terminal Transactivation Domain of p53 J. Biol. Chem., July 1, 2005; 280(26): 25008 - 25021. [Abstract] [Full Text] [PDF]

				Y Zhou, S Eppenberger-Castori, U Eppenberger, and C C Benz The NF{kappa}B pathway and endocrine-resistant breast cancer Endocr. Relat. Cancer, July 1, 2005; 12(Supplement_1): S37 - S46. [Abstract] [Full Text] [PDF]